<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38088735</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1678-4464</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>12</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Cadernos de saude publica</Title><ISOAbbreviation>Cad Saude Publica</ISOAbbreviation></Journal><ArticleTitle>Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort.</ArticleTitle><Pagination><StartPage>e00098023</StartPage><MedlinePgn>e00098023</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00098023</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/0102-311XEN098023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0102-311X2023001205004</ELocationID><Abstract><AbstractText>Most COVID-19 survivors have reported experiencing persistent symptoms after the infection - these types of cases are known as long COVID. Since Brazil was an epicenter of the COVID-19 pandemic, a high burden of long COVID is expected. This study aimed to identify the prevalence and factors associated with long COVID in adults in Southern Brazil, analyzing data from the PAMPA cohort. Participants filled out a self-reported online questionnaire in June 2022. This study only included subjects who tested positive for COVID-19. Long COVID was defined by any symptoms that persisted for at least three months after the SARS-CoV-2 infection. Poisson's regression models with robust variance were used to identify factors associated with long COVID; and results were reported as prevalence ratios (PR) and respective 95% confidence intervals (95%CI). A total of 1,001 participants (77.4% women, mean age [SD] = 38.3 [11.9] years) were analyzed. The prevalence of long COVID among these patients was 77.4% (95%CI: 74.7; 79.9). The likelihood of long COVID was higher in unvaccinated participants (PR = 1.23, 95%CI: 1.06; 1.42), in those with chronic conditions (PR = 1.13, 95%CI: 1.04; 1.24), and in those who were hospitalized due to the COVID-19 infection (PR = 1.24, 95%CI: 1.16; 1.32). This prevalence was also higher in women (PR = 1.21, 95%CI: 1.09; 1.33) than in men. Physical activity was associated with a reduced likelihood of fatigue, neurological complications, coughing, and headaches as persistent symptoms after a COVID-19 infection. It was found that three out of four adults in Southern Brazil experienced long COVID. Public policies aiming to reduce the burden of long COVID must be prioritized, especially in groups that are at higher risk of developing this harmful condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feter</LastName><ForeName>Natan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6295-9792</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caputo</LastName><ForeName>Eduardo Lucia</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0002-3515-9308</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pelotas, Pelotas, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leite</LastName><ForeName>Jayne Santos</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-4612-7301</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delpino</LastName><ForeName>Felipe Mendes</ForeName><Initials>FM</Initials><Identifier Source="ORCID">0000-0002-3562-3246</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pelotas, Pelotas, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Lu&#xed;sa Silveira da</ForeName><Initials>LSD</Initials><Identifier Source="ORCID">0000-0001-6083-3678</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pelotas, Pelotas, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Yohana Pereira</ForeName><Initials>YP</Initials><Identifier Source="ORCID">0000-0003-4828-8210</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande, Rio Grande, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paz</LastName><ForeName>Isabel de Almeida</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0000-0001-5988-3344</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>Juliana Quadros Santos</ForeName><Initials>JQS</Initials><Identifier Source="ORCID">0000-0002-9743-6331</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande, Rio Grande, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Carine Nascimento da</ForeName><Initials>CND</Initials><Identifier Source="ORCID">0000-0001-9908-5291</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande, Rio Grande, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schr&#xf6;eder</LastName><ForeName>Nat&#xe1;lia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3700-6292</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Marcelo Cozzensa da</ForeName><Initials>MCD</Initials><Identifier Source="ORCID">0000-0003-2336-7131</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pelotas, Pelotas, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rombaldi</LastName><ForeName>Airton Jos&#xe9;</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-6707-814X</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Pelotas, Pelotas, Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Cad Saude Publica</MedlineTA><NlmUniqueID>8901573</NlmUniqueID><ISSNLinking>0102-311X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText>A maior parte dos sobreviventes da COVID-19 relatou sintomas persistentes ap&#xf3;s a infec&#xe7;&#xe3;o, tamb&#xe9;m conhecida como COVID longa. O Brasil foi um epicentro da pandemia de COVID-19, logo, espera-se uma alta carga de COVID longa. Este estudo teve como objetivo identificar a preval&#xea;ncia e os fatores associados &#xe0; COVID longa em adultos no Sul do Brasil. Foram analisados dados da coorte PAMPA. Os participantes preencheram um question&#xe1;rio <i>online</i> autoaplic&#xe1;vel em junho de 2022. Foram inclu&#xed;dos apenas os participantes que testaram positivo para COVID-19. A COVID longa foi definida como qualquer sintoma que persistiu por pelo menos tr&#xea;s meses ap&#xf3;s a infec&#xe7;&#xe3;o do SARS-CoV-2. Os modelos de regress&#xe3;o de Poisson com vari&#xe2;ncia robusta foram usados para identificar fatores associados &#xe0; COVID longa; os resultados foram relatados como raz&#xe3;o de preval&#xea;ncia (RP) e seus respectivos intervalos de 95% de confian&#xe7;a (IC95%). Ao todo, 1.001 participantes (77,4% mulheres, idade m&#xe9;dia [DP] = 38,3 [11,9] anos) foram analisados. A preval&#xea;ncia da COVID longa foi de 77,4% (IC95%: 74,7; 79,9). A probabilidade da COVID longa foi maior em participantes n&#xe3;o vacinados (RP = 1,23, IC95%: 1,06; 1,42), pessoas com condi&#xe7;&#xf5;es cr&#xf4;nicas (RP = 1,13, IC95%: 1,04; 1,24), e pacientes hospitalizados devido &#xe0; infec&#xe7;&#xe3;o por COVID-19 (RP = 1,24, IC95%: 1,16; 1,32) em compara&#xe7;&#xe3;o com as contrapartes. A preval&#xea;ncia foi maior em mulheres (RP = 1,21, IC95%: 1,09; 1,33) do que em homens. A atividade f&#xed;sica foi associada &#xe0; probabilidade reduzida de fadiga, complica&#xe7;&#xf5;es neurol&#xf3;gicas, tosse e dor de cabe&#xe7;a como sintomas persistentes ap&#xf3;s a infec&#xe7;&#xe3;o por COVID-19. Tr&#xea;s em cada quatro adultos no Sul do Brasil tiveram COVID longa. Pol&#xed;ticas p&#xfa;blicas que visem reduzir a carga da covid longa devem ser priorizadas, especialmente nos grupos de maior risco desta condi&#xe7;&#xe3;o.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="spa"><AbstractText>La mayor&#xed;a de los supervivientes de la COVID-19 relat&#xf3; s&#xed;ntomas persistentes tras la infecci&#xf3;n, tambi&#xe9;n conocida como COVID largo. Brasil fue un epicentro de la pandemia de COVID-19, as&#xed;, se espera una alta carga de COVID largo. El objetivo de este estudio fue identificar la prevalencia y los factores asociados con la COVID largo en adultos en el Sur de Brasil. Se analizaron datos de la cohorte PAMPA. Los participantes rellenaron un cuestionario en l&#xed;nea autoadministrado en junio de 2022. Solo se incluyeron los participantes que dieron positivo para COVID-19. La COVID largo fue definida como cualquier s&#xed;ntoma que persisti&#xf3; durante al menos tres meses tras la infecci&#xf3;n del SARS-CoV-2. Se utilizaron los modelos de regresi&#xf3;n de Poisson con varianza robusta para identificar factores asociados con el COVID largo; se relataron los resultados como raz&#xf3;n de prevalencia (RP) y sus respectivos intervalos de 95% confianza de 95% (IC95%). En total, se analizaron 1.001 participantes (el 77,4% mujeres, edad media [DP] = 38,3 [11,9] a&#xf1;os). La prevalencia del COVID largo fue del 77,4% (IC95%: 74,7; 79,9). La probabilidad del COVID largo fue m&#xe1;s alta en participantes no vacunados (RP = 1,23, IC95%: 1,06; 1,42), personas con condiciones cr&#xf3;nicas (RP = 1,13, IC95%: 1,04; 1,24) y pacientes hospitalizados debido a la infecci&#xf3;n por COVID-19 (RP = 1,24, IC95%: 1,16; 1,32) en comparaci&#xf3;n con sus contrapartes. La prevalencia fue m&#xe1;s alta en mujeres (RP = 1,21, IC95%: 1,09; 1,33) que en hombres. La actividad f&#xed;sica se asoci&#xf3; con la probabilidad reducida de fatiga, complicaciones neurol&#xf3;gicas, tos y dolor de cabeza como s&#xed;ntomas persistentes tras la infecci&#xf3;n por COVID-19. Tres de cada cuatro adultos en el Sur de Brasil han tenido COVID largo. Se deben priorizar las pol&#xed;ticas p&#xfa;blicas destinadas a reducir la carga del COVID largo, sobre todo en los grupos de mayor riesgo para esta condici&#xf3;n.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>9</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38088735</ArticleId><ArticleId IdType="pmc">PMC10715571</ArticleId><ArticleId IdType="doi">10.1590/0102-311XEN098023</ArticleId><ArticleId IdType="pii">S0102-311X2023001205004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID a meta-analysis and systematic review. J Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N, Steves C, MacDermott N, Morsella A. In the wake of the pandemic: preparing for long COVID. Copenhagen: European Observatory on Health Systems and Policies; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID current definition. Infection. 2022;50:285&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A. More than 50 long-term effects of COVID-19 a systematic review and meta-analysis. Sci Rep. 2021;11:16144&#x2013;16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y-B, Zeng N, Yuan K, Tian S-S, Yang Y-B, Gao N, et al. Prevalence and risk factor for long COVID in children and adolescents: a meta-analysis and systematic review. J Infect Public Health. 2023;16:660&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronav&#xed;rus Brasil  Painel coronav&#xed;rus.  [16/May/2023].  
 https://covid.saude.gov.br/
</Citation></Reference><Reference><Citation>Hallal PC, Hartwig FP, Horta BL, Silveira MF, Struchiner CJ, Vidaletti LP. SARS-CoV-2 antibody prevalence in Brazil results from two successive nationwide serological household surveys. Lancet Glob Health. 2020;8:e1390&#x2013;e1398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511212</ArticleId><ArticleId IdType="pubmed">32979314</ArticleId></ArticleIdList></Reference><Reference><Citation>Paix&#xe3;o B, Baroni L, Pedroso M, Salles R, Escobar L, Sousa C. Estimation of COVID-19 under-reporting in the Brazilian states through SARI. New Gener Comput. 2021;39:623&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955907</ArticleId><ArticleId IdType="pubmed">33746335</ArticleId></ArticleIdList></Reference><Reference><Citation>Feter N, Caputo EL, Doring IR, Leite JS, Cassuriaga J, Reichert FF, et al.  Longitudinal study about low back pain, mental health, and access to healthcare system during COVID-19 pandemic: protocol of an ambispective cohort. medRxiv. 2020 Jul 24; https://www.medrxiv.org/content/10.1101/2020.07.22.20160309v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.22.20160309v1</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Physical status : the use of and interpretation of anthropometry. Geneva: World Health Organization; 1995. (WHO Technical Report Series, 854)</Citation><ArticleIdList><ArticleId IdType="pubmed">8594834</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521200</ArticleId><ArticleId IdType="pubmed">14567763</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic.  [06/May/2023].  
 https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic
.</Citation></Reference><Reference><Citation>Spiers N. Recognising and bearing the burden of long COVID-related disability. Br J Gen Pract. 2022;72:70&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813105</ArticleId><ArticleId IdType="pubmed">35091402</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS. Burden of post-COVID-19 syndrome and implications for healthcare service planning a population-based cohort study. PLoS One. 2021;16:e0254523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J, Wolf A, Hoyo L, H&#xfc;ll E, Tadic M, Andre&#xdf; S, et al. Symptom burden correlates to impairment of diffusion capacity and exercise intolerance in long COVID patients. Sci Rep. 2022;12:8801&#x2013;8801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130688</ArticleId><ArticleId IdType="pubmed">35614108</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelic M, Ziauddeen N, Boyes M, O'Hara ME, Hastie C, Alwan NA. Long COVID stigma: estimating burden and validating scale in a UK-based sample. PLoS One. 2022;17:e0277317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9683629</ArticleId><ArticleId IdType="pubmed">36417364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:3528&#x2013;3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero OJ, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms the LONG-COVID-EXP-CM Multicenter Study. J Clin Med. 2022;11:413&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Bavaro DF, Bonica R. Incidence of long COVID-19 in people with previous SARS-Cov2 infection a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 2023;18:1573&#x2013;1581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Centre for Longitudinal Studies.UCL Institute of Education.University College London . COVID-19 survey in five national longitudinal cohort studies: Millennium Cohort Study, Next Steps, 1970 British Cohort Study and 1958 National Child Development Study, 2020. London: UK Data Service; 2020.</Citation></Reference><Reference><Citation>Galasso V, Pons V, Profeta P, Becher M, Brouard S, Foucault M. Gender differences in COVID-19 attitudes and behavior panel evidence from eight countries. Proc Natl Acad Sci U S A. 2020;117:27285&#x2013;27291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7959517</ArticleId><ArticleId IdType="pubmed">33060298</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic a systematic review and meta-analysis. Global Health. 2020;16:57&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338126</ArticleId><ArticleId IdType="pubmed">32631403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunsch K, Kienberger K, Niessner C. Changes in physical activity patterns due to the COVID-19 pandemic a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:2250&#x2013;2250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8871718</ArticleId><ArticleId IdType="pubmed">35206434</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Reyes LF, Munblit D, Caoili J, Bozza F, Hashmi M. Long COVID in low-income and middle-income countries the hidden public health crisis. Lancet. 2023;402:1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pubmed">37652071</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S, Gualano B, Ara&#xfa;jo AL, Oliveira GN, J&#xfa;nior, Damiano RF, Pinna F. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Sci Rep. 2023;13:215&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813883</ArticleId><ArticleId IdType="pubmed">36604523</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and long COVID a cross-sectional study. Int J Environ Res Public Health. 2022;19:5093&#x2013;5093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzatvar Y, Ram&#xed;rez-V&#xe9;lez R, Izquierdo M, Garcia-Hermoso A. Physical activity and risk of infection, severity and mortality of COVID-19 a systematic review and non-linear dose-response meta-analysis of data from 1,853,610 adults. Br J Sports Med. 2022;56:1188&#x2013;1193.</Citation><ArticleIdList><ArticleId IdType="pubmed">35995587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chastin SFM, Abaraogu U, Bourgois JG, Dall PM, Darnborough J, Duncan E. Effects of regular physical activity on the immune system, vaccination and risk of community-acquired infectious disease in the general population systematic review and meta-analysis. Sports Med. 2021;51:1673&#x2013;1686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056368</ArticleId><ArticleId IdType="pubmed">33877614</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33369898</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson KI, Hillman C, Sullman CM, Ballard RM, Bloodgood B, Conroy DE. Physical activity, cognition, and brain outcomes a review of the 2018 Physical Activity Guidelines. Med Sci Sports Exerc. 2019;51:1242&#x2013;1251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527141</ArticleId><ArticleId IdType="pubmed">31095081</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen BK. Physical activity and muscle-brain crosstalk. Nat Rev Endocrinol. 2019;15:383&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">30837717</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputo EL, Reichert FF. Studies of physical activity and COVID-19 during the pandemic a scoping review. J Phys Act Health. 2020;17:1275&#x2013;1284.</Citation><ArticleIdList><ArticleId IdType="pubmed">33152693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F. Trajectory of long covid symptoms after COVID-19 vaccination community based cohort study. BMJ. 2022;377:e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Perrodeau E, Saldanha J, Pane I, Ravaud P. Efficacy of first dose of COVID-19 vaccine versus no vaccination on symptoms of patients with long COVID: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2:e000229</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P. Risk factors associated with post-COVID-19 condition a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2022;55:101762&#x2013;101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM. Fatigue and cognitive impairment in post-COVID-19 syndrome a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D. Population risk factors for severe disease and mortality in COVID-19 a global systematic review and meta-analysis. PLoS One. 2021;16:e0247461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract. 2020;166:108293&#x2013;108293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332436</ArticleId><ArticleId IdType="pubmed">32623035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A, Sen R, Ferrucci L. Does a bit of alcohol turn off inflammation and improve health. Age Ageing. 2016;45:747&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">27555047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C. Outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland study. Nat Commun. 2022;13:5663&#x2013;5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus. Geneva: World Health Organization; 2021.</Citation></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;23:618&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, Sampaio VS, Ozahata MC, Lopes R, Brito AF, Bragatte M. Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020-2022. Infect Control Hosp Epidemiol. 2023;5:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10755155</ArticleId><ArticleId IdType="pubmed">37272468</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>